These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19479657)

  • 21. Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians.
    Hamadeh IS; Shahin MH; Lima SM; Oliveira F; Wilson L; Khalifa SI; Langaee TY; Cooper-DeHoff RM; Cavallari LH; Johnson JA
    Clin Transl Sci; 2016 Feb; 9(1):36-42. PubMed ID: 26751406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualizing warfarin therapy.
    Reynolds KK; Valdes R; Hartung BR; Linder MW
    Per Med; 2007 Feb; 4(1):11-31. PubMed ID: 29793302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.
    French B; Joo J; Geller NL; Kimmel SE; Rosenberg Y; Anderson JL; Gage BF; Johnson JA; Ellenberg JH;
    Trials; 2010 Nov; 11():108. PubMed ID: 21083927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrosequencing of the CYP2C9 -1766T>C polymorphism as a means of detecting the CYP2C9*8 allele.
    Patel SR; Langaee TY; Wong SS; Cavallari LH
    Pharmacogenomics; 2014 Sep; 15(13):1717-22. PubMed ID: 25410896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin Pharmacogenetics: New Life for an Old Drug.
    Wen MS; Lee MT
    Acta Cardiol Sin; 2013 May; 29(3):235-42. PubMed ID: 27122712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral anticoagulation: a critique of recent advances and controversies.
    Pirmohamed M; Kamali F; Daly AK; Wadelius M
    Trends Pharmacol Sci; 2015 Mar; 36(3):153-63. PubMed ID: 25698605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of warfarin with drugs, natural substances, and foods.
    Greenblatt DJ; von Moltke LL
    J Clin Pharmacol; 2005 Feb; 45(2):127-32. PubMed ID: 15647404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomic-guided dosing for warfarin: too little too late?
    Wu AH
    Per Med; 2018 Mar; 15(2):71-73. PubMed ID: 29714120
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of cytochrome P450 genotype in the steps toward personalized drug therapy.
    Cavallari LH; Jeong H; Bress A
    Pharmgenomics Pers Med; 2011; 4():123-36. PubMed ID: 23226058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits of pharmacogenomics in drug development-earlier launch of drugs and less adverse events.
    Ohashi W; Tanaka H
    J Med Syst; 2010 Aug; 34(4):701-7. PubMed ID: 20703925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethnic Diversity and Warfarin Pharmacogenomics.
    Asiimwe IG; Pirmohamed M
    Front Pharmacol; 2022; 13():866058. PubMed ID: 35444556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective.
    Drozda K; Pacanowski MA; Grimstein C; Zineh I
    JACC Basic Transl Sci; 2018 Aug; 3(4):545-549. PubMed ID: 30175278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Counterpoint: pharmacogenetic-based initial dosing of warfarin: not ready for prime time.
    Eby CS
    Clin Chem; 2009 Apr; 55(4):712-4. PubMed ID: 19233915
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine.
    Barone C; Mousa SS; Mousa SA
    Pharmgenomics Pers Med; 2009; 2():59-67. PubMed ID: 23226035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Admixture and ethno-specific alleles: missing links for global pharmacogenomics.
    Duconge J; Ruaño G
    Pharmacogenomics; 2016 Sep; 17(14):1479-82. PubMed ID: 27537834
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen.
    Wigle TJ; Jansen LE; Teft WA; Kim RB
    J Pers Med; 2017 Dec; 7(4):. PubMed ID: 29236081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pacific Symposium on Biocomputing--computational approaches for pharmacogenomics.
    Wilke RA; Carrillo MW; Ritchie MD
    Pharmacogenomics; 2005 Mar; 6(2):111-3. PubMed ID: 15882130
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacogenomics of warfarin from the COAG and EU-PACT: where do we go from here?
    Wu AH; Superko HR
    Per Med; 2014 May; 11(3):247-249. PubMed ID: 29764060
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacogenetics of warfarin: clinical implications].
    Takahashi H
    Nihon Ronen Igakkai Zasshi; 2010; 47(1):38-40. PubMed ID: 20339202
    [No Abstract]   [Full Text] [Related]  

  • 40. Interactions of warfarin with drugs and food.
    Wells PS; Holbrook AM; Crowther NR; Hirsh J
    Ann Intern Med; 1994 Nov; 121(9):676-83. PubMed ID: 7944078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.